Betamethasone Dipropionate: Medgend

Betamethasone Dipropionate FDA Approved Drugs

BETAMETHASONE DIPROPIONATE [Betamethasone Dipropionate^{C₂₈H₃₇FO₇}]

eq 0.05% base (topical ointment, augmented)

Actavis Mid Atlantic^{Aug 31, 1995}
Fougera^{Sep 4, 1984}
Fougera Pharms^{Dec 9, 2003}
Fougera Pharms Inc^{Aug 12, 1985}
G And W Labs Inc^{Aug 10, 1987}
Glenmark Generics^{Sep 23, 2008}
Perrigo New York^{Dec 9, 2003}
Taro^{Apr 30, 1992}
Tolmar^{Jan 23, 2004}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE [Betamethasone Dipropionate^{C₂₈H₃₇FO₇} : Calcipotriene Hydrate^{C₂₇H₄₀O₃H₂O}]

0.064% : 0.005% (topical ointment)

Perrigo Israel^{Dec 12, 2014}
Tolmar^{Jan 14, 2013}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE [Betamethasone Dipropionate^{C₂₈H₃₇FO₇} : Clotrimazole^{C₂₂H₁₇ClN₂}]

eq 0.05% base : 1% (topical cream)

Actavis Mid Atlantic^{Aug 2, 2002}
Fougera Pharms^{Jun 16, 2005}
Glenmark Pharms^{Oct 30, 2015}
Taro^{Jul 28, 2004}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

DIPROLENE [Betamethasone Dipropionate^{C₂₈H₃₇FO₇}]

eq 0.05% base (topical lotion, augmented)

Merck Sharp Dohme^{Aug 1, 1988}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

DIPROLENE AF [Betamethasone Dipropionate^{C₂₈H₃₇FO₇}]

eq 0.05% base (topical cream, augmented)

Merck Sharp Dohme^{Apr 27, 1987}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

ENSTILAR [Betamethasone Dipropionate^{C₂₈H₃₇FO₇} : Calcipotriene^{C₂₇H₄₀O₃}]

0.064% : 0.005% (topical aerosol, foam)

Leo Pharma As^{Oct 16, 2015}

Plaque psoriasis.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

LOTRISONE [Betamethasone Dipropionate^{C₂₈H₃₇FO₇} : Clotrimazole^{C₂₂H₁₇ClN₂}]

eq 0.05% base : 1% (topical lotion)

Merck Sharp Dohme^{Dec 8, 2000}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

SERNIVO [Betamethasone Dipropionate^{C₂₈H₃₇FO₇}]

eq 0.05% base/spray (topical spray)

Promius Pharma Llc^{Feb 5, 2016}

Treatment of plaque psoriasis.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

TACLONEX [Betamethasone Dipropionate^{C₂₈H₃₇FO₇} : Calcipotriene Hydrate^{C₂₇H₄₀O₃H₂O}]

0.064% : 0.005% (topical ointment)

Leo Pharma As^{Jan 9, 2006}

Psoriasis.
Treatment of moderate plaque psoriasis.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.